231 UPDATE OF RESPONSE TO TREATMENT WITH AZACITIDINE AND DECITABINE IN HIGH-RISK MDS PATIENTS FROM THE DUESSELDORF MDS REGISTRY – 10 YEARS EXPERIENCE WITH HYPOMETHYLATING TREATMENT. Issue 1 (April 2015) - Neukirchen, J.; Schuck, A.; Götte, M.C.; Kündgen, A.; Kobbe, G.; Haas, R.; Germing, U.